Author | Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor,


Pandemic Fears Stoke Calls for New Vaccines and Global Health Initiatives

Pharmaceutical Executive


Public health authorities and the biomedical research community are seeking new strategies to address global health threats, writes Jill Wechsler.

FDA Moves Forward on Mutual GMP Inspections with Europe


The agency hopes to better use global resources and avoid duplicate inspections of foreign facilities.

Prices, Opioids, and Ethics Dominate FDA Confirmation Hearing


Scott Gottlieb answers Senators' questions at his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee.

Gottlieb to Face User Fees, De-Regulation Pressures


Trump’s choice for FDA commissioner faces drug pricing, regulatory, and approval challenges.